GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

22 hedge funds and large institutions have $8.36M invested in Galmed Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$262K
2
BIT
2
BlackRock Institutional Trust
California
$117K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$38K
4
BA
4
BlackRock Advisors
Delaware
$21K
5
Morgan Stanley
5
Morgan Stanley
New York
$67K

Top Sellers

1
CAD
1
Craig A. Drill
$160K
2
VKH
2
Virtu KCG Holdings
New York
$0
3
SIM
3
Spark Investment Management
New York
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$109K
5
Goldman Sachs
5
Goldman Sachs
New York
$422K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– -$6K -4 Closed
1
2